This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Inner Mongolia Kingdomway Pharmaceutical Co., Ltd., Jiangsu Chengxin Pharmaceutical Co., Ltd., Kingdomway Biotechnology (Jiangsu) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Fei Xu: Innovator in Coenzyme Production
Introduction
Fei Xu is a notable inventor based in Nantong, China. He has made significant contributions to the field of biochemistry, particularly in the production of coenzymes. His innovative processes have the potential to impact various industries, including pharmaceuticals and biotechnology.
Latest Patents
Fei Xu holds a patent for "Processes for producing reduced coenzyme Q." This patent outlines methods for preparing a reaction mixture that includes oxidized CoQ, a reductase, a supplemental coenzyme, a coenzyme regeneration enzyme, and a substrate for the regeneration enzyme. The processes described allow for the effective production of reduced CoQ, which is essential for various biological functions.
Career Highlights
Throughout his career, Fei Xu has worked with prominent companies in the biotechnology sector. He has been associated with Kingdomway Biotechnology (Jiangsu) Co., Ltd. and Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in biotechnological applications and product development.
Collaborations
Fei Xu has collaborated with several professionals in his field, including Jun Zhu and Bingrong Wang. These collaborations have fostered innovation and the sharing of knowledge, further enhancing the impact of his work.
Conclusion
Fei Xu's contributions to the production of coenzymes demonstrate his commitment to innovation in biotechnology. His patent and career achievements reflect his expertise and the potential for future advancements in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile